MedTrace Logo

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

NCT02567539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2022-09-15

No results posted yet for this study

Summary

The study is aimed to evaluate efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.

Conditions

  • Recurrent High Grade Glioma

Interventions

RADIATION

IMRT with or without radiosensitive therapy

Re-irradiation with hypofractionated intensity modulated radiation therapy (IMRT), using VMAT RapidArc

DRUG

Radiosensitive therapy

Radiosensitive therapy with Temozolomide

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Piera Navarria, MD · Istituto Clinico Humanitas

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-27
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567539 on ClinicalTrials.gov